Registry of Standard Biological Models

A collection of models of biological parts that can be freely reused and composed with each other to produce more complex models. A draft implementation of the registry is underway and collaborators are being sought.
Talk to us at - BioSysBio 2007, SB3.0, and iGEM Jamboree Workshop 2007
Goals To contribute to the Open Source Synthetic Biology effort. To store, curate and support models related to physical Biobricks. To drive and guide the experimental characterization of BioBricks. To enable the reuse of modular part models. To provide a forum for modelers to contribute to the BioBricks effort.	Activities Planning the architecture of a registry of standard biological models. Building a collection of standard biological models. Define a modeling description language that is: Machine readable Capable of describing gene expression networks Modular (standardized defined inputs/ouputs) Hierarchical (models are composable) Capable of describing models that can be related to experimental data.

---

Recent edits:

List of abbreviations: N This edit created a new page (also see list of new pages) m This is a minor edit b This edit was performed by a bot (±123) The page size changed by this number of bytes 20 May 2024      19:36  CHEM-ENG590E:Wiki Textbook‎ diffhist −125‎ Sarah L. Perry talk contribs (→‎Chapter 9 - Microfluidics and Cell Culture)      19:33  Organ/Tumor/Body-on-a-Chip - Organ on a Chip - Michele Caggioni‎‎ 49 changes history −3,492‎ [Sarah L. Perry‎ (49×)]       19:33 (cur | prev) −2,021‎ Sarah L. Perry talk contribs       19:32 (cur | prev) +69‎ Sarah L. Perry talk contribs (→‎Future Work and Ultimate Goals)       19:31 (cur | prev) −3‎ Sarah L. Perry talk contribs (→‎Body-on-a-chip Limitations)       19:30 (cur | prev) +9‎ Sarah L. Perry talk contribs (→‎Body-on-a-chip Advantages)       19:28 (cur | prev) +2‎ Sarah L. Perry talk contribs       19:25 (cur | prev) +523‎ Sarah L. Perry talk contribs (→‎Scalability of Tumor-On-A-Chip Based Drug Screening)       19:25 (cur | prev) +1,250‎ Sarah L. Perry talk contribs (→‎Drug Screening)       19:20 (cur | prev) −1,679‎ Sarah L. Perry talk contribs (→‎Body-on-a-chip Limitations)       19:19 (cur | prev) −355‎ Sarah L. Perry talk contribs       19:12 (cur | prev) −31‎ Sarah L. Perry talk contribs (→‎Organ-on-a-Chip Advantages and Disadvantages)       19:11 (cur | prev) +8‎ Sarah L. Perry talk contribs (→‎Body-on-a-chip Advantages)       19:10 (cur | prev) −100‎ Sarah L. Perry talk contribs (→‎Body-on-a-chip (integration of multiple organ-on-a-chips) Advantages & Limitations)       19:08 (cur | prev) +4‎ Sarah L. Perry talk contribs (→‎Scalability of Tumor-On-A-Chip Based Drug Screening)       19:07 (cur | prev) −480‎ Sarah L. Perry talk contribs (→‎Scalability of Tumor-On-A-Chip Based Drug Screening)       19:02 (cur | prev) −40‎ Sarah L. Perry talk contribs (→‎Drug Screening)       18:58 (cur | prev) −14‎ Sarah L. Perry talk contribs (→‎Modeling)       18:56 (cur | prev) −134‎ Sarah L. Perry talk contribs (→‎Tumor Spheroid Production)       18:52 (cur | prev) +3‎ Sarah L. Perry talk contribs (→‎Tumor Spheroid Production)  m    18:51 (cur | prev) −1‎ Sarah L. Perry talk contribs (→‎Role of Microfluidics in Cancer Research)       18:51 (cur | prev) +9‎ Sarah L. Perry talk contribs (→‎Role of Microfluidics in Cancer Research)  m    18:50 (cur | prev) +21‎ Sarah L. Perry talk contribs (→‎Role of Microfluidics in Cancer Research Abroad)       18:46 (cur | prev) +9‎ Sarah L. Perry talk contribs (→‎Modeling Drug Delivery: Overview and Motivation)       18:45 (cur | prev) +4‎ Sarah L. Perry talk contribs (→‎Modeling Non-Cancerous Cell Components of the Tumor Microenvironment)       18:45 (cur | prev) +14‎ Sarah L. Perry talk contribs (→‎Modeling Non-Cancerous Cell Components of the Tumor Microenvironment)       18:45 (cur | prev) −4‎ Sarah L. Perry talk contribs (→‎Modeling the Biochemical Regulation of Cancer Proliferation)       18:44 (cur | prev) +12‎ Sarah L. Perry talk contribs (→‎Modeling the Biochemical Regulation of Cancer Proliferation)       18:44 (cur | prev) +8‎ Sarah L. Perry talk contribs (→‎Modeling the Biochemical Regulation of Cancer Proliferation)       18:43 (cur | prev) +14‎ Sarah L. Perry talk contribs (→‎Modeling the Biochemical Regulation of Cancer Proliferation)       18:43 (cur | prev) +10‎ Sarah L. Perry talk contribs (→‎Modeling Non-Cancerous Cell Components of the Tumor Microenvironment)       18:42 (cur | prev) +9‎ Sarah L. Perry talk contribs (→‎Modeling the Biochemical Regulation of Cancer Proliferation)       18:40 (cur | prev) −92‎ Sarah L. Perry talk contribs (→‎Introduction-Modeling Tumor Death: Microfluidics and Biomimetic Tumor Spheroids)       18:35 (cur | prev) −166‎ Sarah L. Perry talk contribs (→‎Introduction-Modeling Tumor Death: Microfluidics and Biomimetic Tumor Spheroids)  m    18:32 (cur | prev) −1‎ Sarah L. Perry talk contribs (→‎Kidney-on-a-Chip)  m    18:29 (cur | prev) 0‎ Sarah L. Perry talk contribs (→‎Lung-on-a-Chip)  m    18:28 (cur | prev) +1‎ Sarah L. Perry talk contribs (→‎Liver-on-a-Chip)       18:24 (cur | prev) −61‎ Sarah L. Perry talk contribs (→‎Kidney-on-a-Chip)       18:23 (cur | prev) −60‎ Sarah L. Perry talk contribs (→‎Lung-on-a-Chip)       18:22 (cur | prev) −62‎ Sarah L. Perry talk contribs (→‎Liver-on-a-Chip)       18:21 (cur | prev) −1‎ Sarah L. Perry talk contribs       18:20 (cur | prev) −14‎ Sarah L. Perry talk contribs (→‎Liver-on-a-Chip)       18:18 (cur | prev) +16‎ Sarah L. Perry talk contribs (→‎Body-on-a-chip)       18:17 (cur | prev) −246‎ Sarah L. Perry talk contribs (→‎Body-on-a-chip)       18:07 (cur | prev) +3‎ Sarah L. Perry talk contribs (→‎Body-on-a-chip)  m    17:52 (cur | prev) +4‎ Sarah L. Perry talk contribs (→‎Body-on-a-chip)       17:51 (cur | prev) −44‎ Sarah L. Perry talk contribs (→‎Organ-on-a-chip Advantages)  m    17:48 (cur | prev) 0‎ Sarah L. Perry talk contribs (→‎Organ on a Chip Advantages and Disadvantages)       17:47 (cur | prev) −23‎ Sarah L. Perry talk contribs (→‎Conventional Systems)  m    17:45 (cur | prev) +23‎ Sarah L. Perry talk contribs (→‎Conventional Systems)       17:44 (cur | prev) +115‎ Sarah L. Perry talk contribs (→‎Conventional Systems)

---

• See this page for a draft implementation.
• See this page for a draft on model implementations following CellML 1.1.